BANK VONTOBEL/CALL/STRYKER CORP./400/0.1/20.09.24 Stock

Warrant

DE000VD0NPN3

Delayed Deutsche Boerse AG 01:42:48 2024-05-22 pm EDT
0.078 EUR +41.82% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./400/0.1/20.09.24
Current month-74.00%
1 month-64.55%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.078 +41.82%
24-05-21 0.055 -1.79%
24-05-20 0.056 -29.11%
24-05-17 0.079 -1.25%
24-05-16 0.08 +5.26%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 01:42 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD0NPN
ISINDE000VD0NPN3
Date issued 2024-02-20
Strike 400 $
Maturity 2024-09-20 (121 Days)
Parity 10 : 1
Emission price 0.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.07
Lowest since issue 0.048
Spread 0.022
Spread %21.36%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.4 USD
Average target price
372.4 USD
Spread / Average Target
+11.01%
Consensus